GMAT Question of the Day - Daily to your Mailbox; hard ones only

 It is currently 16 Oct 2019, 10:01

### GMAT Club Daily Prep

#### Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

# A large pharmaceutical firm recently introduced a newer version of its

Author Message
TAGS:

### Hide Tags

Manager
Joined: 10 Apr 2018
Posts: 223
Location: India
Concentration: Entrepreneurship, Strategy
GMAT 1: 680 Q48 V34
GPA: 3.3
A large pharmaceutical firm recently introduced a newer version of its  [#permalink]

### Show Tags

25 Feb 2019, 03:55
00:00

Difficulty:

25% (medium)

Question Stats:

79% (02:02) correct 21% (02:17) wrong based on 70 sessions

### HideShow timer Statistics

A large pharmaceutical firm recently introduced a newer version of its . The new product is identical to the basic version except that it includes an ingredient to alleviate nausea, the most common side effect of the basic remedy. However, during the first six months that both products were on the market, the company sold more than six times as much of the basic remedy as it did of the newer version. The pharmaceutical company therefore decided that avoiding side effects was not the primary consideration of customers who bought its headache remedies.

Which of the following, if true, would most call into question the pharmaceutical company's conclusion?

A. The pharmaceutical company sells its headache remedies to hospitals and clinics as well as to retail distributors.

C. The new headache remedy and the basic headache remedy both cause side effects other than nausea in less than 1 percent of all users.

D. Because of the risk of unknown or unexpected side effects, many customers avoid new pharmaceutical products until they have been proven to be safe over time.

E. No significant difference in price exists between the new headache remedy and the basic headache remedy.
Director
Joined: 20 Sep 2016
Posts: 634
Location: India
Concentration: Strategy, Operations
GPA: 3.95
WE: Operations (Real Estate)
Re: A large pharmaceutical firm recently introduced a newer version of its  [#permalink]

### Show Tags

25 Feb 2019, 06:24
A large pharmaceutical firm recently introduced a newer version of its . The new product is identical to the basic version except that it includes an ingredient to alleviate nausea, the most common side effect of the basic remedy. However, during the first six months that both products were on the market, the company sold more than six times as much of the basic remedy as it did of the newer version. The pharmaceutical company therefore decided that avoiding side effects was not the primary consideration of customers who bought its headache remedies.

Understand :
new prod = basic prod
ONLY new prod reduces MOST COMMON SIDE effect of the basic
fist 6 months stats : new prod sold = x ...basic prod = 6x

conclsuin : avoiding side effect = NOT primary

Think : In what sitaution will the ppl choose basic prod even if their primary consideration is avoiding side effects !!
Now the argument says avoids the MOST COMMON SIDE EFFECT...but what if the new prod actually worsens one of the other side effects??? or gives rise to a new side effect??? what if the new ingreduent" actually has some neative result too ??
Then even though the primary consideration is acoiding nausea , the ppl may be scared of the above avg pain suffered from other side effefects???

Weaken framework : We want an answer choice which would tell us the PRIMARY CONSIDERATION may actually be acoiding side effects BUT still ppl chose basic !!

Which of the following, if true, would most call into question the pharmaceutical company's conclusion?

A. The pharmaceutical company sells its headache remedies to hospitals and clinics as well as to retail distributors.
- Irrelevant

-Other prods : out o scipe

C. The new headache remedy and the basic headache remedy both cause side effects other than nausea in less than 1 percent of all users.

Quote:
D. Because of the risk of unknown or unexpected side effects, many customers avoid new pharmaceutical products until they have been proven to be safe over time.
- This hingesupon ppls ears !!! so even if ppl want t avoid side effects what if they are scared of even worse or other side effects of the new prod before ppl are sure that new is good !!! This gives us AN ALTERNATE casue !!!

E. No significant difference in price exists between the new headache remedy and the basic headache remedy.[/quote]
- price : irrelevant !!
Re: A large pharmaceutical firm recently introduced a newer version of its   [#permalink] 25 Feb 2019, 06:24
Display posts from previous: Sort by